Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stereosarc: Atezolizumab + SBRT vs SBRT Alone in Oligometastatic Sarcomas
NCT03548428Phase 2Recruiting
- Sponsor
- Centre Antoine Lacassagne
- Start
- Jun 2020
- Primary completion
- Feb 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in soft tissue sarcoma (STS), sponsored by Centre Antoine Lacassagne. Started Jun 2020; status: recruiting.
02
Drugs
atezolizumab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03548428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03548428.